ASO Visual Abstract: Impact of Insurance Status on Oncologic and Perioperative Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

被引:0
|
作者
Hanna, David N. [1 ]
Ghani, Muhammad O. [1 ]
Hermina, Andrew [2 ]
Mina, Alexander [3 ]
Bailey, Christina E. [1 ]
Idrees, Kamran [1 ]
Magge, Deepa [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Div Surg Oncol & Endocrine Surg, Sect Surg Sci, Nashville, TN 37235 USA
[2] Meharry Med Coll, Nashville, TN 37208 USA
[3] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
关键词
D O I
10.1245/s10434-021-10742-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:685 / 686
页数:2
相关论文
共 50 条
  • [1] ASO Visual Abstract: Impact of Insurance Status on Oncologic and Perioperative Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    David N. Hanna
    Muhammad O. Ghani
    Andrew Hermina
    Alexander Mina
    Christina E. Bailey
    Kamran Idrees
    Deepa Magge
    Annals of Surgical Oncology, 2021, 28 : 685 - 686
  • [2] Impact of Insurance Status on Oncologic and Perioperative Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    Hanna, D.
    Ghani, M.
    Hermina, A.
    Mina, A.
    Bailey, C.
    Idrees, K.
    Magge, D.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S116 - S116
  • [3] Impact of Insurance Status on Oncologic and Perioperative Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    David N. Hanna
    Muhammad O. Ghani
    Andrew Hermina
    Alexander Mina
    Christina E. Bailey
    Kamran Idrees
    Deepa Magge
    Annals of Surgical Oncology, 2022, 29 : 253 - 259
  • [4] Impact of Insurance Status on Oncologic and Perioperative Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
    Hanna, David N.
    Ghani, Muhammad O.
    Hermina, Andrew
    Mina, Alexander
    Bailey, Christina E.
    Idrees, Kamran
    Magge, Deepa
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (01) : 253 - 259
  • [5] ASO Author Reflections: Disparate Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Based on Insurance Status
    David N. Hanna
    Deepa Magge
    Annals of Surgical Oncology, 2022, 29 : 260 - 261
  • [6] ASO Author Reflections: Disparate Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Based on Insurance Status
    Hanna, David N.
    Magge, Deepa
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (01) : 260 - 261
  • [7] ASO Visual Abstract: Functional Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy—A Prospective Cohort Study
    Preet G. S. Makker
    Cherry E. Koh
    Nabila Ansari
    Nicole Gonzaga
    Jenna Bartyn
    Michael Solomon
    Daniel Steffens
    Annals of Surgical Oncology, 2023, 30 : 461 - 461
  • [8] ASO Visual Abstract: Oncologic Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Highly Selected Patients with Metastatic Pancreatic Ductal Adenocarcinoma
    Gudmundsdottir, Hallbera
    Yonkus, Jennifer A.
    Thiels, Cornelius A.
    Warner, Susanne G.
    Cleary, Sean P.
    Kendrick, Michael L.
    Truty, Mark J.
    Grotz, Travis E.
    ANNALS OF SURGICAL ONCOLOGY, 2023,
  • [9] ASO Visual Abstract: Oncologic Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Highly Selected Patients with Metastatic Pancreatic Ductal Adenocarcinoma
    Gudmundsdottir, Hallbera
    Yonkus, Jennifer A.
    Thiels, Cornelius A.
    Warner, Susanne G.
    Cleary, Sean P.
    Kendrick, Michael L.
    Truty, Mark J.
    Grotz, Travis E.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) : 7872 - 7873
  • [10] ASO Visual Abstract: Oncologic Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Highly Selected Patients with Metastatic Pancreatic Ductal Adenocarcinoma
    Hallbera Gudmundsdottir
    Jennifer A. Yonkus
    Cornelius A. Thiels
    Susanne G. Warner
    Sean P. Cleary
    Michael L. Kendrick
    Mark J. Truty
    Travis E. Grotz
    Annals of Surgical Oncology, 2023, 30 : 7872 - 7873